Laursen JC, Rotbain Curovic V, Kroonen MYAM, Jongs N, et al. Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial. Diabetes Obes Metab 2023 Jun 29. doi: 10.1111/dom.15180.
PMID: 37385968